Efficacy News and Research

RSS
Galapagos initiates phase II clinical study of GLPG0259 drug in RA patients

Galapagos initiates phase II clinical study of GLPG0259 drug in RA patients

SORT-OUT IV trial compares XIENCE V, CYPHER Stent in major acute coronary events

SORT-OUT IV trial compares XIENCE V, CYPHER Stent in major acute coronary events

Study investigates link between cough and reflux events using sound recording device

Study investigates link between cough and reflux events using sound recording device

PGIC analysis indicates tapentadol ER tablets provide significant improvement in pain intensity

PGIC analysis indicates tapentadol ER tablets provide significant improvement in pain intensity

Pfizer ceases SUN 1120 Phase 3 trial of SUTENT in men with CRPC

Pfizer ceases SUN 1120 Phase 3 trial of SUTENT in men with CRPC

Chelsea Therapeutics initiates CH-4051 Phase II trial in rheumatoid arthritis patients

Chelsea Therapeutics initiates CH-4051 Phase II trial in rheumatoid arthritis patients

REMURA Phase 2 clinical study results highlighted at Tear Film & Ocular Surface conference

REMURA Phase 2 clinical study results highlighted at Tear Film & Ocular Surface conference

S*BIO initiates SB939 Phase 2 clinical trial for metastatic prostate cancer

S*BIO initiates SB939 Phase 2 clinical trial for metastatic prostate cancer

MediciNova receives FDA approval to proceed with initial trial of ibudilast

MediciNova receives FDA approval to proceed with initial trial of ibudilast

Hospira's Nivestim receives Australian TGA approval

Hospira's Nivestim receives Australian TGA approval

Boston releases HORIZONS-AMI trial data

Boston releases HORIZONS-AMI trial data

FDA approves Beyaz tablets to increase folate level in women

FDA approves Beyaz tablets to increase folate level in women

Gene alteration impacts brain tumor development: Study

Gene alteration impacts brain tumor development: Study

Clinical Data announces Stedivaze agonist data at ASNC2010 meeting

Clinical Data announces Stedivaze agonist data at ASNC2010 meeting

FDA approves OZURDEX implant for uveitis treatment

FDA approves OZURDEX implant for uveitis treatment

Genta commences new tesetaxel Phase 2 clinical trial in advanced bladder cancer

Genta commences new tesetaxel Phase 2 clinical trial in advanced bladder cancer

Enobia announces positive results from ENB-0040 Phase II juvenile clinical trial for hypophosphatasia

Enobia announces positive results from ENB-0040 Phase II juvenile clinical trial for hypophosphatasia

Concerted effort yields significant progress in reducing depression, HIV/AIDS, and osteoporosis in women

Concerted effort yields significant progress in reducing depression, HIV/AIDS, and osteoporosis in women

Global leaders announce new commitments to accelerate progress towards ending malaria deaths

Global leaders announce new commitments to accelerate progress towards ending malaria deaths

Phase 3 clinical study demonstrates efficacy of metformin therapy in type 2 diabetes

Phase 3 clinical study demonstrates efficacy of metformin therapy in type 2 diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.